Reposted by @id-jd-pharmd.bsky.social
@id-jd-pharmd.bsky.social: Rapid BCID improved MSSA BSI care compared to conventional cx-based methods by enabling earlier β lactam therapy, leading to more desirable DOOR outcomes and⬇️AKI. Findings highlight the impact of faster organism ID in optimizing patient outcomes. doi.org/10.1017/ash....
